Vaxxas

Vaxxas begins clinical trial of first needle-free inactivated seasonal flu vaccine

14-Feb-2023 By Jane Byrne

Australia’s Vaxxas has initiated a Phase I clinical trial with the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate.

Spotlight

Women in Science - Emmanuelle Cameau on growing stronger from challenges

Women in Science - Beate Mueller on the privilege of bringing solutions closer to patients

EU approves Regeneron’s bispecific antibody following US rejection

FDA approval of Regeneron’s myeloma drug delayed due to manufacturing issues

Breaking News: Lecanemab approved in UK but unavailable on NHS

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Adcendo and Multitude target cancer resistance to ADCs in $1BN deal

Follow us

Most popular News

1 Eli Lilly reports positive phase 3 results for a weekly insulin formulation

Webinars

Upcoming supplier webinars

17 Sep 2024 Tue Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Featured Suppliers

All